Sitagliptin
Showing 1 - 25 of 485
Polycystic Ovary Syndrome Trial in Bani Suwayf (Sitagliptin 100mg)
Not yet recruiting
- Polycystic Ovary Syndrome
- Sitagliptin 100mg
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Aug 1, 2023
PDAC - Pancreatic Ductal Adenocarcinoma Trial (Combination of sitagliptin+ gemcitabine + nab-paclitaxel)
Not yet recruiting
- PDAC - Pancreatic Ductal Adenocarcinoma
- Combination of sitagliptin+ gemcitabine + nab-paclitaxel
- (no location specified)
Jul 9, 2023
Type 2 Diabetes Trial in Beijing (Sitagliptin, Sitagliptin combined with Beidougen capsule)
Recruiting
- Type 2 Diabetes
- Sitagliptin
- Sitagliptin combined with Beidougen capsule
-
Beijing, Beijing, ChinaBeijing Chao-yang Hospital, Capital Medical University
Dec 29, 2022
Compensated Cirrhosis, Decompensated Cirrhosis Trial in New Delhi (Metformin, Sitagliptin, Dapagliflozin)
Not yet recruiting
- Compensated Cirrhosis
- Decompensated Cirrhosis
- Metformin
- +2 more
-
New Delhi, Delhi, IndiaDr Rakesh Kumar Jagdish
Nov 23, 2023
Perioperative Sitagliptin Medication for Reduction of
Recruiting
- Systemic Inflammatory Response Syndrome
- Sitagliptin
-
Münster, North Rhine-Westphalia, GermanyUniversity Hospital Münster
Feb 10, 2023
Type 1 Diabetic Nephropathy Trial in Cairo (oral sitagliptin supplementation)
Completed
- Type 1 Diabetic Nephropathy
- oral sitagliptin supplementation
-
Cairo, EgyptNancy Elbarbary
Nov 2, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 50/500 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
-
San Pedro Garza Garcia, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bone Marrow Transplant Complications, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Adult Trial in Indianapolis
Not yet recruiting
- Bone Marrow Transplant Complications
- +4 more
- Sitagliptin
- +2 more
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
May 30, 2023
Healthy Volunteers (Intended Indication: Type 2 Diabetes) Trial in Berlin (Dapagliflozin/sitagliptin FDC, Sitagliptin,
Completed
- Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)
- Dapagliflozin/sitagliptin FDC
- +2 more
-
Berlin, GermanyResearch Site
Jun 30, 2022
Diabetes, Type 2 Diabetes Trial (Sitagliptin, Metformin, Placebo to sitagliptin)
Completed
- Diabetes Mellitus
- Type 2 Diabetes
- Sitagliptin
- +5 more
- (no location specified)
Sep 9, 2022
Bioequivalence, Type 2 Diabetes Trial in Mount Royal (Sitagliptin/metformin HCl (HCl) 50/1000 mg film-coated tablet)
Completed
- Bioequivalence
- Type 2 Diabetes
- Sitagliptin/metformin hydrochloride (HCl) 50/1000 mg film-coated tablet
-
Mount Royal, Quebec, CanadaAlgorithme Pharma
Sep 20, 2022
Bioequivalence, Diabetes, Type 2 Trial in Mount Royal (Sitagliptin/Metformin HCl 50/850 mg film-coated tablet)
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 50/850 mg film-coated tablet
-
Mount Royal, Quebec, CanadaAlgorithme Pharma
Sep 20, 2022
Healthy Subjects Trial in Cheongju-si (SID1903 (FDC), Dapagliflozin and Sitagliptin)
Completed
- Healthy Subjects
- SID1903 (FDC)
- Dapagliflozin and Sitagliptin
-
Cheongju-si, Korea, Republic ofChungbuk National University Hospital
Oct 24, 2022
Type 2 Diabetes Trial in Mexico City (Sitagliptin 100mg, Glargine, Lispro)
Recruiting
- Type 2 Diabetes
- Sitagliptin 100mg
- +2 more
-
Mexico City, MexicoDivisión de Investigación en Salud, Hospital de Especialidades,
Oct 11, 2022
Diabetes Type I Trial in Williamsville (sitagliptin, Placebo)
Withdrawn
- Diabetes Type I
- sitagliptin
- Placebo
-
Williamsville, New York115 Flint Road
Mar 8, 2022
Type 1 Diabetes Trial in Milan (Sitagliptin, Professional CGM)
Not yet recruiting
- Type 1 Diabetes
- Sitagliptin
- Professional CGM
-
Milan, ItalyASST FBF Sacco
Jun 14, 2022
Combination of Ertugliflozin And Sitagliptin Efficacy, Safety &
Not yet recruiting
- Efficacy
- +2 more
- Combinations of Oral Blood Glucose Lowering Drugs
- (no location specified)
Oct 3, 2022
Quality of Life, Type 2 Diabetes, Metformin+Sitagliptin Trial in Karachi (Metformin / Sitagliptin Oral Tablet)
Completed
- Quality of Life
- +2 more
- Metformin / Sitagliptin Oral Tablet
-
Karachi, Sindh, PakistanPrimary Care Diabetes Association
Apr 28, 2022
NAFLD Trial (sitagliptin and metformin, Sitagliptin, Metformin)
Completed
- NAFLD
- sitagliptin and metformin
- +2 more
- (no location specified)
Jul 28, 2022
Liver Transplant; Complications, Diabetes, NASH - Nonalcoholic Steatohepatitis Trial (Semaglutide Treatment, Sitagliptin 100mg)
Not yet recruiting
- Liver Transplant; Complications
- +3 more
- Semaglutide Treatment
- Sitagliptin 100mg
- (no location specified)
Jun 17, 2022
Type 2 Diabetes Trial in Buffalo (Januvia (Sitagliptin) 100 mg, Placebo)
Completed
- Type 2 Diabetes
- Januvia (Sitagliptin) 100 mg
- Placebo
-
Buffalo, New York115 Flint Road
Feb 2, 2022